Senior Program Development Consultant
Judy Magruder has served as an advisor to emerging start-up and established pharmaceutical companies on development of in-line and pipeline products and opportunities with deep experience in key disciplines of drug development, facilitating effective program management to define, track, troubleshoot and meet business goals. Successfully developed small molecules, biologics, drug-device combinations, oral dosage forms, injectables, implants, transdermal and microneedle patches and a track record of building successful cross-functional teams especially at early stage innovators and significantly impacting achievement of project goals.
Judy received an MBA from Santa Clara University and a BS in Animal Science from the University of California Davis. Prior to joining DSI, Judy was an Independent Consultant and has held noteworthy roles in Program management and operations on the west coast at Zosano Pharma, Signature Therapeutics, DURECT Corporation and ALZA Corporation.
Senior Biologics Manufacturing Consultant
Dave is a technical operation executive and consultant with a very diverse background in biopharmaceuticals. A change agent with proven ability to transform teams, design and construct manufacturing facilities, and lead product development from process development through commercialization. Over a 30-year career, Dave managed Chemistry, Manufacturing and Control (CMC) operations staff, engineers, and development scientists; ranging up to 55 employees.
His Consultant experience includes:
Dave began his career in manufacturing at GENENTECH and progressed to biological process R&D at Idec, Biomarin, and Optimer Pharmaceuticals. Dave joined DSI in 2020 from Vaxart as an expert biologics consultant whose career focus has evolved toward applying principles of quality risk assessment and sound science to provide CMC guidance to all aspects of biological process drug development. Dave holds a B.S. in Biochemistry Magna Cum Laude from San Francisco State University.
